Booming antibodies 2001
MasterControl - Learn How to Avoid Obstacles in Pharma Manufacturing
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Jellagen ® Ltd announces a collaboration with the Mayo Clinic

Wednesday, September 30, 2020

Jellagen® Limited, a marine biotechnology company producing high-value collagen derived from jellyfish, has entered into a licensing agreement to grant exclusive patent rights for the development to the Mayo Clinic treatment of vocal cord paralysis.

Vocal cord paralysis (VCP) is an injury to one or both of the recurrent laryngeal nerves (RLN) that control most of the muscles in the larynx, resulting in paralysis of the vocal cord muscles, which in turn can result in l airway obstruction, dyspnoea, vocal changes, etc. Vocal cord paralysis is caused by the side effects of surgery, trauma, cancer, and more.

The original text of this announcement, written in the source language, is the authentic official version. Translations are offered solely for the convenience of the reader and must refer to the original text, which is the only legally valid text.

Contacts
Adam Watts, Digital Marketing Manager at Jellagen
Tel .: +44 (0) 3333 583 299
www.jellagen.co.uk

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA Bora Pharmaceuticals - CMDO making success Medical Fair Asia 2022 Medical Manufacturing Asia 2022